Repeated blockade of 5-HT 7 receptors depresses glutamatergic transmission in the rat frontal cortex

Journal of Physiology and Pharmacology

Volumn 63, Issue 2, 2012, Pages 173-177

  Tokarski, K ^a   Kusek, M ^a   Hess, G ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Adaptive changes; Brain; Glutamate; Pyramidal neurons; Serotonin; Serotonin receptor antagonist

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; GLUTAMIC ACID; SEROTONIN 7 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EX VIVO STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FRONTAL CORTEX; GLUTAMATERGIC TRANSMISSION; INTRACELLULAR RECORDING; MALE; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PYRAMIDAL NERVE CELL; RAT; REPEATED DRUG DOSE; SINGLE DRUG DOSE; TREATMENT DURATION; WHOLE CELL;

ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; FRONTAL LOBE; GLUTAMIC ACID; MALE; PHENOLS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES;

EID: 84861868813     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992; 72: 165-229.
2. Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 1993; 268: 23422-23426.
3. Ruat M, Traiffort E, Leurs R, et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 1993; 90: 8547-8551.
4. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71: 533-554.
5. To ZP, Bonhaus DW, Eglen RM, Jakeman LB. Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol 1995; 115: 107-116.
6. Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M. Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 2001; 21: 63-73.
7. Martin-Cora FJ, Pazos A. Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. Br J Pharmacol 2004; 141: 92-104.
8. Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 1998; 51: 215-235.
9. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 2004; 25: 481-486.
10. Thomas DR, Hagan JJ. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 2004; 3: 81-90.
11. Tokarski K, Zahorodna A, Bobula B, Grzegorzewska M, Pitra P, Hess G. Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors. Eur J Pharmacol 2005; 524: 60-66.
12. Guscott M, Bristow LJ, Hadingham K, et al. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 2005; 48: 492-502.
13. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 2005; 58: 831-837.
14. Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E. Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 2006; 51: 578-586.
15. Bonaventure P, Kelly L, Aluisio L, et al. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 2007; 321: 690-698.
16. Wesolowska A, Tatarczynska E, Nikiforuk A, Chojnacka-Wojcik E. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur J Pharmacol 2007; 555: 43-47.
17. Mnie-Filali O, Faure C, Lambas-Senas L, et al. Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 2011; 36: 1275-1288.
18. Tokarski K, Bobula B, Kusek M, Hess G. The 5-HT7 receptor antagonist SB 269970 counteracts restraint stress-induced attenuation of long-term potentiation in rat frontal cortex. J Physiol Pharmacol 2011; 62: 663-667.
19. Paul A, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann NY Acad Sci 2003; 1003: 250-272.
20. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005; 10: 808-819.
21. Palucha A, Pilc A. The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 2005; 18: 262-268.
22. Schechter LE, Ring RH, Beyer CE, et al. Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2005; 5: 590-611.
23. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001; 7: 541-547.
24. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 2005; 58: 843-853.
25. Krishnan V, Nestler EJ. Molecular neurobiology of depression. Nature 2008; 455: 894-902.
26. Bobula B, Tokarski K, Hess G. Repeated administration of antidepressants decreases field potentials in rat frontal cortex. Neuroscience 2003; 120: 765-769.
27. Tokarski K, Bobula B, Wabno J, Hess G. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience 2008; 153: 789-795.
28. Tokarski K, Kusek M, Hess G. 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol 2011; 62: 535-540.
29. Tokarski K, Zahorodna A, Bobula B, Hess G. 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res 2003; 993: 230-234.
30. Bekisz M, Garkun Y, Wabno J, Hess G, Wrobel A, Kossut M. Increased excitability of cortical neurons induced by associative learning: an ex vivo study. Eur J Neurosci 2010; 32: 1715-1725.
31. O'Hearn E, Molliver ME. Organization of raphe-cortical projections in rat: a quantitive retrograde study. Brain Res Bull 1984; 13: 709-726.
32. Fink KB, Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 2007; 59: 360-417.
33. Calcagno E, Carli M, Invernizzi RW. The 5-HT1A receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. J Neurochem 2006; 96: 853-860.
34. Golembiowska K, Dziubina A. Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex. Pol J Pharmacol 2002; 54: 625-631.
35. Maura G, Marcoli M, Tortarolo M, Andrioli, M. Raiteri M. Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors. Br J Pharmacol 1998; 123: 45-50.
36. Wesolowska A, Kowalska M. Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 2008; 60: 464-474.
37. Roberts C, Thomas DR, Bate ST, Kew JN. GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 2004; 46: 935-941.
38. Harsing LG. The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat. Curr Neuropharmacol 2006; 4: 313-339.
39. Duncan MJ, Temel S, Jennes L. Localization of serotonin 5-HT7 receptor immunoreactivity in the rat brain. Soc Neurosci Abstr 2001; 380: 18.
40. Glass JD, Grossman GH, Farnbauch L, DiNardo L. Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J Neurosci 2003; 23: 7451-7460.
41. Kvachnina E, Liu G, Dityatev A, et al. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci 2005; 25: 7821-7830.
42. Corset V, Nguyen-Ba-Charvet KT, Forcet C, Moyse E, Chedotal A, Mehlen P. Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor. Nature 2000; 407: 747-750.
43. Yu JZ, Dave RH, Allen JA, Sarma T, Rasenick MM. Cytosolic G(alpha)s acts as an intracellular messenger to increase microtubule dynamics and promote neurite outgrowth. J Biol Chem 2009; 284: 10462-10472.
44. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-269.
45. Kobe F, Guseva D, Jensen TP, et al. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci 2012; 32: 2915-2930.